Clinical Trial Update: Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults [Phase 3]

View source ↗

Summary

Phase 3 trial updating on consistency across three lots of a live-attenuated chikungunya vaccine in healthy adults; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya Virus Infection

Drugs mentioned

• Chikungunya vaccine candidate (live-attenuated)

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Chikungunya Virus Infection | Phase 3 | Status: COMPLETED | Results posted: 2023-09-28